APVOVSGOSS• 28 Days (Normalized)
APVO vs GOSS (Aptevo Therapeutics Inc. vs Gossamer Bio Inc.)
Showing Closing Date Range from Aug, 17 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
APVO Performance $1.85
-34.16%
Aptevo Therapeutics Inc.
Normalized Baseline0.00%
GOSS Performance $10.8
+7610.71%
Gossamer Bio Inc.
Normalized Baseline0.00%
Alpha Spread Margin GOSS LEADS
-7644.87%
GOSS outperforming by 7644.87%
APVOGOSS
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
APVO GOSS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | APVO Price | APVO Gain (%) | GOSS Price | GOSS Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $1.85 | -34.16% | $10.80 | +7610.71% | -7644.87% |
| Sep 11, 2026 | $1.82 | -35.23% | $10.73 | +7564.29% | -7599.52% |
| Sep 10, 2026 | $1.83 | -34.88% | $11.36 | +8014.29% | -8049.17% |
| Sep 09, 2026 | $1.85 | -34.34% | $12.80 | +9042.86% | -9077.20% |
| Sep 08, 2026 | $1.88 | -33.10% | $14.40 | +10185.71% | -10218.81% |
| Sep 04, 2026 | $1.74 | -38.08% | $14.00 | +9900.00% | -9938.08% |
| Sep 03, 2026 | $1.71 | -39.15% | $14.05 | +9934.29% | -9973.44% |
| Sep 02, 2026 | $2.60 | -7.47% | $0.17 | +23.57% | -31.04% |
| Sep 01, 2026 | $2.34 | -16.73% | $0.17 | +19.29% | -36.02% |
| Aug 31, 2026 | $2.44 | -13.17% | $0.17 | +21.43% | -34.60% |
| Aug 28, 2026 | $2.37 | -15.84% | $0.17 | +21.43% | -37.27% |
| Aug 27, 2026 | $2.42 | -13.88% | $0.17 | +21.43% | -35.31% |
| Aug 26, 2026 | $2.41 | -14.23% | $0.17 | +24.29% | -38.52% |
| Aug 25, 2026 | $2.46 | -12.46% | $0.21 | +46.43% | -58.89% |
| Aug 24, 2026 | $2.41 | -14.23% | $0.18 | +25.00% | -39.23% |
Page 1 of 2